29 reports

Bipolar Disorder - Epidemiology Forecast to 2030 Summary Bipolar disorder, also known as bipolar depression or manic depression, is a psychological disorder that presents with severe shifts in mood from one extreme to another.The mood swings occur in a cyclic or periodic pattern that includes...

  • Bipolar Disorder
  • Epidemiology
  • World
  • Depression Prevalence
  • Prescription Drug Sales

Bipolar Disorder market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Bipolar Disorder Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Bipolar Disorder types, applications. Further, Bipolar Disorder market...

  • Bipolar Disorder
  • World

Abstract: What`s New for 2022? -Global competitiveness and key competitor percentage market shares -Market presence across multiple geographies - Strong/Active/Niche/Trivial -Online interactive peer-to-peer collaborative bespoke updates -Access to our digital archives and MarketGlass...

  • Bipolar Disorder
  • Therapy
  • Antipsychotic
  • World
  • China
  • Depression Prevalence
  • Mortality Rate

Bipolar Disorder Market Report Overview Bipolar Disorder market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Bipolar Disorder market types and applications. It is a focused study on Bipolar Disorder market space including global and regional...

  • Bipolar Disorder
  • World
  • Health Provider Density

Bipolar Disorder (Manic Depression) (Central Nervous System) - Drugs in Development, 2021 Summary Bipolar Disorder (Manic Depression) (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Bipolar Disorder (Manic Depression) pipeline landscape. The report provides...

  • Bipolar Disorder
  • Neurology
  • World

The ongoing clinical trial research report- “2019 Bipolar Disorder Ongoing Clinical Trials Study” analyzes the current scenario of all active Bipolar Disorder trials across the world. The report presents top level analysis of global Bipolar Disorder clinical trials across countries, companies and universities. It is designed to provide clear...

  • Bipolar Disorder
  • Clinical Trial
  • World
  • APAC

This study covers the world outlook for bipolar disorder drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These...

  • Bipolar Disorder
  • World
  • Gross Domestic Product
  • Disposable Income

Bipolar Disorder - Global Drug Forecast and Market Analysis to 2030 Summary Bipolar disorder, known originally as manic-depressive illness, is a mental disorder characterized by periods of mania and depression.Manic episodes are the distinguishing feature of this condition and consist of an abnormally...

  • Bipolar Disorder
  • World
  • Depression Prevalence
  • Drug Approval

About Bipolar Disorder Bipolar disorder is also known as manic depression that causes extreme shifts in mood, energy, and activity levels. Elevated mood swings are called mania or hypomania, which differs based on the severity and presence of psychosis. Bipolar disorder is a long-lasting condition that can be categorized...

  • Bipolar Disorder
  • World

Bipolar Disorder (Manic Depression) ongoing clinical trials report provides comprehensive analysis and trends in global Bipolar Disorder (Manic Depression) disease clinical trials. The research work analyzes the ongoing Bipolar Disorder (Manic Depression) clinical trial trends across countries and companies. The report focuses on drugs...

  • Bipolar Disorder
  • Clinical Trial
  • World

Bipolar Disorder Market Analysis By Drug Class (Mood stabilizer, Anticonvulsant, Antipsychotic, Antidepressant, Antianxiety), By Mechanism of Action, By Region, And Segment Forecasts, 2014 - 2025 The global bipolar disorder market is anticipated to reach USD 4.9 billion by 2025, growing at a CAGR of 2.10% Government...

  • Bipolar Disorder
  • World
  • North America

Drug Overview  Abilify (aripiprazole; Otsuka/Lundbeck) is an atypical antipsychotic that contains aripiprazole, a partial agonist of dopamine receptor D2 and serotonin receptor 5-HT1A, and antagonist of the 5-HT2A receptor. Abilify’s partial agonist activity at the D2 receptors allows it to act as a dopamine stabilizer...

  • Antipsychotic
  • Cardiovascular Drug
  • Bipolar Disorder
  • United States
  • European Union

Seroquel/Seroquel XR

8770 10000 7800

Drug Overview  The Seroquel franchise contains quetiapine, which acts as an antagonist at multiple neurotransmitter receptors in the brain, such as serotonin 5-HT1A and 5-HT2, dopamine D1 and D2, histamine H1, and adrenergic alpha 1 and alpha 2 receptors.  AstraZeneca initially launched Seroquel in the...

  • Bipolar Disorder
  • Europe
  • Japan
  • United States

Drug Overview: Zyprexa

8770 10000 7800

Drug Overview Zyprexa (Eli Lilly) contains the atypical antipsychotic olanzapine, which acts as an antagonist at the D2 and 5-HT2A receptors. Zyprexa was initially launched in September 1996 for the treatment of schizophrenia. Eli Lilly subsequently pursued development in bipolar disorder and received the first approval...

  • Antipsychotic
  • Bipolar Disorder

Drug Overview: Geodon

8770 10000 7800

Drug Overview  Geodon contains ziprasidone, a dopamine (D2) and serotonin (5-HT2) antagonist developed and marketed by Pfizer. Geodon initially launched in the US in 2001 for the treatment of schizophrenia. It subsequently gained approval for bipolar disorder indications in the US and EU in August 2004 and October...

  • Bipolar Disorder
  • Psychotic Disorder
  • Antipsychotic
  • Japan
  • United States
  • European Union

Drug Overview  Risperdal Consta (Johnson&Johnson) contains risperidone, an atypical antipsychotic that acts as a selective dopamine and serotonin receptor antagonist that also blocks the dopamine D2, serotonin (5-HT2), and alpha-2 adrenergic receptors. Risperdal Consta is the long-acting injectable formulation...

  • Bipolar Disorder
  • Antipsychotic
  • Cardiovascular Drug
  • Hormone
  • United States
  • European Union

Drug Overview  Lamictal (GlaxoSmithKline) contains lamotrigine, a phenyltriazine antiepileptic drug that acts at voltage-sensitive sodium channels to stabilize neuronal membranes and inhibits the release of excitatory amino acid neurotransmitters. Lamictal initially launched as an adjunctive treatment for epilepsy...

  • Bipolar Disorder
  • Antipsychotic
  • Hospital
  • United States
  • European Union

The 5 Key Questions Addressed by this Report: • How many physicians were reached by Seroquel XR through personal promotion in 2016 and how does this compare to its peer set in the Bipolar Disorder, Manic Episodes, and Schizophrenia markets? • What promotional mix was leveraged (e.g., sales rep detailing, physician education,...

  • Health Care Provider
  • Bipolar Disorder
  • United States

Bipolar Disorder (Manic Depression) - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bipolar Disorder (Manic Depression) – Pipeline Review, H2 2016, provides an overview of the Bipolar Disorder (Manic Depression) (Central Nervous System) pipeline...

  • Bipolar Disorder
  • Depression
  • World
  • Depression Prevalence
  • Diagnostic Imaging Density

Disease Overview Bipolar disorder is a psychiatric disorder characterized by unusual shifts in mood, energy, activity levels, and the ability to carry out everyday tasks. Patients with the disorder may experience periods of mania (an overly joyful or overexcited state) followed by periods of depression (feelings of extreme...

  • Bipolar Disorder
  • Drug Approval

Generic dominance will prevent the growth of the bipolar disorder market, and few pipeline candidates show promise to completely reverse this trend. This report addresses the following questions: - What are the key events shaping the bipolar disorder market dynamics over 2014–23? - Which segments of the market provide...

  • Bipolar Disorder
  • United States
  • Japan
  • European Union
  • Depression Prevalence
  • Drug Approval

Bipolar Disorder (Manic Depression) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Bipolar Disorder (Manic Depression) - Pipeline Review, H1 2016’, provides an overview of the Bipolar Disorder (Manic Depression) pipeline landscape. The report provides comprehensive information on the therapeutics...

  • Bipolar Disorder
  • World
  • Diagnostic Imaging Density
  • Depression Prevalence

Bipolar Disorder - Current and Future Players Summary GlobalData has released its pharma report, “Bipolar Disorder - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Bipolar Disorder Market. The report identifies and analyses...

  • Bipolar Disorder
  • World
  • Drug Approval
  • Prescription Drug Sales

Bipolar Disorder - Canada Drug Forecast and Market Analysis to 2024 Summary Bipolar disorder is a mental disorder characterized by periods of mania and depression. The frequency, severity, and pattern of these episodes can vary considerably over time and between individuals, making bipolar disorder one of the most challenging...

  • Bipolar Disorder
  • World
  • Depression Prevalence
  • Drug Approval

Bipolar Disorder - US Drug Forecast and Market Analysis to 2024 Summary Bipolar disorder is a mental disorder characterized by periods of mania and depression. The frequency, severity, and pattern of these episodes can vary considerably over time and between individuals, making bipolar disorder one of the most challenging...

  • Bipolar Disorder
  • World
  • Depression Prevalence
  • Drug Approval

Bipolar Disorder - Japan Drug Forecast and Market Analysis to 2024 Summary Bipolar disorder is a mental disorder characterized by periods of mania and depression. The frequency, severity, and pattern of these episodes can vary considerably over time and between individuals, making bipolar disorder one of the most challenging...

  • Bipolar Disorder
  • World
  • Depression Prevalence
  • Drug Approval

EpiCast Report: Bipolar Disorder - Epidemiology Forecast to 2024 Summary Bipolar disorder, also known as bipolar depression or manic depression, is a psychological disorder that presents with severe shifts in mood from one extreme to another. The mood swings occur in a cyclic or periodic pattern that includes feelings...

  • Bipolar Disorder
  • United States
  • Japan
  • Canada
  • World
  • Depression Prevalence
  • Smoking Prevalence

About bipolar disorder therapeutics Bipolar disorder is a psychological disorder characterized by intermittent mood swings. The individual suffering with this disorder experiences extreme poles of either mania or depression or both. The disorder severely affects the personal, social, and professional life of an individual. The symptoms...

  • Bipolar Disorder
  • Pharmaceutical
  • United States
  • Drug Approval
  • Prescription Drug Sales

PharmaPoint: Bipolar Disorder - Global Drug Forecast and Market Analysis to 2024 Summary Bipolar disorder is a mental disorder characterized by periods of mania and depression. The frequency, severity, and pattern of these episodes can vary considerably over time and between individuals, making bipolar disorder one...

  • Bipolar Disorder
  • World
  • Depression Prevalence
  • Drug Approval